|
Recombinant Thyrotropin Alfa Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Recombinant TSH Alpha, Recombinant Thyrotropin Alpha, TSH-alpha, Thyrogen, Thyroid Stimulating Hormone Alpha, Thyrotropin Alfa
Duarte, California1 trial
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.